search
Back to results

Impact of Digital Therapeutic on Metabolic Parameters

Primary Purpose

Insulin Resistance, Prediabetic State, Diabetes Mellitus, Type 2

Status
Completed
Phase
Not Applicable
Locations
Czechia
Study Type
Interventional
Intervention
Vitadio
Conventional high-intensity lifestyle intervention program
Sponsored by
Vitadio s.r.o.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Insulin Resistance

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • obesity with body mass index (BMI) above 30 kg/m^2
  • insulin resistance or prediabetes or type 2 diabetes mellitus
  • acess to device with internet access (notebook, smartphone, tablet)
  • willingness and ability to comply with all scheduled visits, laboratory tests, lifestyle considerations and other study procedures

Exclusion Criteria:

  • pregnancy
  • steroid treatment
  • type 2 diabetes mellitus on insulin therapy
  • severe renal and/or hepatic impairment
  • any impairments including mental and psychological or conditions which, in the opinion of the investigator, would seriously compromise the integrity of the study
  • inability to understand, consent to, or comply with the study protocol for any reason, including inability to read or comprehend Czech language
  • inability to comply with study procedures

Sites / Locations

  • University Hospital Olomouc

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Participants using Vitadio

Participants assigned to conventional high-intensity lifestyle intervention program

Arm Description

Participants in the intervention arm undergo a 6-month digitally administered behavioral change program Vitadio focused on lifestyle change and self-management. The program aims for strengthening patients autonomy with the goal to promote weight loss and improve metabolic health. The program includes personalized education, adaptive daily tasks and weekly goals, automated motivational and educational messaging, monitoring tools, recipes, peer-support group and one-on-one remote coaching. In addition, they undergo regular face-to-face medical assessment.

Participants in the control group undergo a 6-month high-intensity lifestyle intervention program consisting of of 5 face-to-face nutrition/lifestyle education sessions. Participants can use an online diary tool for recording meals with an option to receive remote feedback on their diet from the educator. In addition, they undergo regular face-to-face medical assessment.

Outcomes

Primary Outcome Measures

Change in body weight
comparison of baseline and end program body weight

Secondary Outcome Measures

change in waist circumference
comparison of baseline, three-month and end-program waist circumference between groups
change in body mass index (BMI)
comparison of baseline, three-month and end-program body mass index (BMI) between groups
change in haemoglobin A1c
comparison of baseline, three-month and end-program haemoglobin A1c values between groups
change in adherence to lifestyle intervention
comparison of baseline, three-month and end-program adherence to healthy lifestyle assigned both by subjective (adapted questionnaire) and objective (program usage frequency, attrition) measures between groups
change in blood glucose
comparison of baseline, three-month and end-program blood glucose values between groups
change in insulin resistance
comparison of baseline, three-month and end-program insulin resistance quantified by HOMA-IR between groups
change in blood pressure
comparison of baseline, three-month and end-program blood pressure between groups
change in body composition
comparison of baseline, three-month and end-program body composition assessed with the InBody bioelectrical impedance analysis device between groups
change in resting metabolic rate (RMR)
comparison of baseline, three-month and end-program resting metabolic rate assessed by indirect calorimetry between groups
change in cardiorespiratory fitness
comparison of baseline, three-month and end-program cardiorespiratory fitness assessed by spiroergometry between groups
change in lipid parameters (total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides)
comparison of baseline, three-month and end-program levels of total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides between groups
change in fasting insulin levels
comparison of baseline, three-month and end-program fasting insulin levels between groups
change in liver function tests
comparison of baseline, three-month and end-program standard liver panel (ALT, AST, GGT, ALP) values between groups

Full Information

First Posted
September 29, 2020
Last Updated
August 30, 2023
Sponsor
Vitadio s.r.o.
Collaborators
University Hospital Olomouc
search

1. Study Identification

Unique Protocol Identification Number
NCT04573296
Brief Title
Impact of Digital Therapeutic on Metabolic Parameters
Official Title
Impact of Digital Therapeutic Intervention on Metabolic Parameters in Obese Adults With Insulin Resistance, Prediabetes and Type 2 Diabetes as Compared to Conventional Intensive Obesity Management Programme
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Completed
Study Start Date
February 26, 2020 (Actual)
Primary Completion Date
November 30, 2022 (Actual)
Study Completion Date
November 30, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Vitadio s.r.o.
Collaborators
University Hospital Olomouc

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this prospective randomized controlled study is to evaluate the impact of a six-month digitally administered behavioral change program on body weight, glycemic control and other metabolic parameters in obese adults with insulin resistance, prediabetes or type 2 diabetes as compared to conventional high-intensity lifestyle intervention program administered at a specialized department of a university hospital.
Detailed Description
In this prospective randomized clinical study, obese adults with insulin resistance, prediabetes or diabetes mellitus type 2, patients of the Department of Exercise Medicine and Cardiovascular Rehabilitation at the University Hospital Olomouc, are randomized to receive either Vitadio or a conventional 6-month high-intensity lifestyle intervention program at the clinic. Vitadio is a mobile application delivering behavioral change program focused on lifestyle change and self-management. The program aims for strengthening patients autonomy with the goal to promote weight loss and improve metabolic health. The program includes personalized education, adaptive daily tasks and weekly goals, automated motivational and educational messaging, monitoring tools, recipes, peer-support group and one-on-one remote coaching. Personalization of the intervention is achieved by analyzing participant's interactions with the application. The conventional therapy consists of 5 face-to-face nutrition/lifestyle education sessions (at baseline, at 1st, 2nd and 3rd month, and at month 6). Participants in the control group can use an online diary tool for recording meals with an option to receive remote feedback on their diet from the educator. In addition, all participants undergo a regular medical assessment at the clinic (baseline, month 3, month 6). The aim of the study is to assess feasibility and efficacy of digitally administered intervention by comparing evolution of weight, physical fitness, laboratory measures of metabolic health, blood pressure and other outcomes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Insulin Resistance, Prediabetic State, Diabetes Mellitus, Type 2, Obesity

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This prospective randomized controlled study evaluates efficacy of lifestyle intervention using digital application Vitadio as compared to conventional high-intensity lifestyle intervention program administered at a specialized clinic at a University hospital.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Participants using Vitadio
Arm Type
Experimental
Arm Description
Participants in the intervention arm undergo a 6-month digitally administered behavioral change program Vitadio focused on lifestyle change and self-management. The program aims for strengthening patients autonomy with the goal to promote weight loss and improve metabolic health. The program includes personalized education, adaptive daily tasks and weekly goals, automated motivational and educational messaging, monitoring tools, recipes, peer-support group and one-on-one remote coaching. In addition, they undergo regular face-to-face medical assessment.
Arm Title
Participants assigned to conventional high-intensity lifestyle intervention program
Arm Type
Active Comparator
Arm Description
Participants in the control group undergo a 6-month high-intensity lifestyle intervention program consisting of of 5 face-to-face nutrition/lifestyle education sessions. Participants can use an online diary tool for recording meals with an option to receive remote feedback on their diet from the educator. In addition, they undergo regular face-to-face medical assessment.
Intervention Type
Device
Intervention Name(s)
Vitadio
Intervention Description
A 6-month digitally administered behavioral change program Vitadio focus on lifestyle change and self-management. The program aims for strengthening patients autonomy with the goal to promote weight loss and improve metabolic health. The program includes personalized education, adaptive daily tasks and weekly goals, automated motivational and educational messaging, monitoring tools, recipes, peer-support group and remote coaching.
Intervention Type
Behavioral
Intervention Name(s)
Conventional high-intensity lifestyle intervention program
Intervention Description
A 6-month high-intensity lifestyle intervention program consisting of 5 face-to-face nutrition/lifestyle education sessions. Participants can use an online diary tool for recording meals with an option to receive remote feedback on their diet from the educator.
Primary Outcome Measure Information:
Title
Change in body weight
Description
comparison of baseline and end program body weight
Time Frame
baseline, three months, six months
Secondary Outcome Measure Information:
Title
change in waist circumference
Description
comparison of baseline, three-month and end-program waist circumference between groups
Time Frame
baseline, three months, six months
Title
change in body mass index (BMI)
Description
comparison of baseline, three-month and end-program body mass index (BMI) between groups
Time Frame
baseline, three months, six months
Title
change in haemoglobin A1c
Description
comparison of baseline, three-month and end-program haemoglobin A1c values between groups
Time Frame
baseline, three months, six months
Title
change in adherence to lifestyle intervention
Description
comparison of baseline, three-month and end-program adherence to healthy lifestyle assigned both by subjective (adapted questionnaire) and objective (program usage frequency, attrition) measures between groups
Time Frame
baseline, three months, six months
Title
change in blood glucose
Description
comparison of baseline, three-month and end-program blood glucose values between groups
Time Frame
baseline, three months, six months
Title
change in insulin resistance
Description
comparison of baseline, three-month and end-program insulin resistance quantified by HOMA-IR between groups
Time Frame
baseline, three months, six months
Title
change in blood pressure
Description
comparison of baseline, three-month and end-program blood pressure between groups
Time Frame
baseline, three months, six months
Title
change in body composition
Description
comparison of baseline, three-month and end-program body composition assessed with the InBody bioelectrical impedance analysis device between groups
Time Frame
baseline, three months, six months
Title
change in resting metabolic rate (RMR)
Description
comparison of baseline, three-month and end-program resting metabolic rate assessed by indirect calorimetry between groups
Time Frame
baseline, three months, six months
Title
change in cardiorespiratory fitness
Description
comparison of baseline, three-month and end-program cardiorespiratory fitness assessed by spiroergometry between groups
Time Frame
baseline, three months, six months
Title
change in lipid parameters (total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides)
Description
comparison of baseline, three-month and end-program levels of total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides between groups
Time Frame
baseline, three months, six months
Title
change in fasting insulin levels
Description
comparison of baseline, three-month and end-program fasting insulin levels between groups
Time Frame
baseline, three months, six months
Title
change in liver function tests
Description
comparison of baseline, three-month and end-program standard liver panel (ALT, AST, GGT, ALP) values between groups
Time Frame
baseline, three months, six months
Other Pre-specified Outcome Measures:
Title
Vitadio usability for HCPs
Description
The healthcare professionals' (HCPs) user experience from interacting with Vitadio Health, assessed with the User Experience Questionnaire (UEQ)
Time Frame
six months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: obesity with body mass index (BMI) above 30 kg/m^2 insulin resistance or prediabetes or type 2 diabetes mellitus acess to device with internet access (notebook, smartphone, tablet) willingness and ability to comply with all scheduled visits, laboratory tests, lifestyle considerations and other study procedures Exclusion Criteria: pregnancy steroid treatment type 2 diabetes mellitus on insulin therapy severe renal and/or hepatic impairment any impairments including mental and psychological or conditions which, in the opinion of the investigator, would seriously compromise the integrity of the study inability to understand, consent to, or comply with the study protocol for any reason, including inability to read or comprehend Czech language inability to comply with study procedures
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Katarína Moravcová, MD
Organizational Affiliation
University Hospital Olomouc
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital Olomouc
City
Olomouc
ZIP/Postal Code
779 00
Country
Czechia

12. IPD Sharing Statement

Learn more about this trial

Impact of Digital Therapeutic on Metabolic Parameters

We'll reach out to this number within 24 hrs